Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report
- PMID: 30791209
- DOI: 10.1111/hdi.12733
Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: A case report
Abstract
Chemotherapy and extracorporeal treatment reduce serum free light chains (FLCs) allowing the recovery of acute kidney injury (AKI) caused by myeloma cast nephropathy (MCN). We report the first case of recovery from AKI in a patient with MCN who underwent the removal of FLCs using the PEPA filter, with an undisclosed cut-off, combined with chemotherapy for multiple myeloma (MM).
Keywords: Bortezomib; Multiple myeloma; PEPA (Poly Ester Polymer Alloy); cast nephropathy; dialysis; free light chains.
© 2019 The Authors. Hemodialysis International published by Wiley Periodicals, Inc. on behalf of International Society for Hemodialysis.
Comment in
-
A comment on "Early use of a PEPA (polyester polymer alloy) dialyzer for light chain removal and for the recovery from myeloma cast nephropathy: A case report".Hemodial Int. 2020 Apr;24(2):261. doi: 10.1111/hdi.12816. Epub 2020 Feb 12. Hemodial Int. 2020. PMID: 32052559 No abstract available.
-
Reply. A comment on "Early use of a PEPA (polyester polymer alloy) dialyzer for light chain removal and for the recovery from myeloma cast nephropathy: A case report".Hemodial Int. 2020 Apr;24(2):262-263. doi: 10.1111/hdi.12813. Epub 2020 Feb 25. Hemodial Int. 2020. PMID: 32100404 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
